These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 6833262
1. Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats. Fasco MJ, Preusch PC, Hildebrandt E, Suttie JW. J Biol Chem; 1983 Apr 10; 258(7):4372-80. PubMed ID: 6833262 [Abstract] [Full Text] [Related]
5. Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone. Mukharji I, Silverman RB. Proc Natl Acad Sci U S A; 1985 May 10; 82(9):2713-7. PubMed ID: 3857611 [Abstract] [Full Text] [Related]
9. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats. Hallak HO, Wedlund PJ. Drug Metab Dispos; 1991 Jan 25; 19(1):278-9. PubMed ID: 1673414 [No Abstract] [Full Text] [Related]
10. Vitamin K1 hydroquinone formation catalyzed by a microsomal reductase system. Fasco MJ, Principe LM. Biochem Biophys Res Commun; 1980 Dec 31; 97(4):1487-92. PubMed ID: 7213374 [No Abstract] [Full Text] [Related]
11. Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase. Hazelett SE, Preusch PC. Biochem Pharmacol; 1988 Mar 01; 37(5):929-34. PubMed ID: 3345202 [Abstract] [Full Text] [Related]
12. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase. Creedon KA, Suttie JW. Thromb Res; 1986 Oct 15; 44(2):147-53. PubMed ID: 3787564 [Abstract] [Full Text] [Related]
13. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes. Fasco MJ, Principe LM, Walsh WA, Friedman PA. Biochemistry; 1983 Nov 22; 22(24):5655-60. PubMed ID: 6652076 [Abstract] [Full Text] [Related]
14. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction. Lee JJ, Principe LM, Fasco MJ. Biochemistry; 1985 Dec 03; 24(25):7063-70. PubMed ID: 4084561 [Abstract] [Full Text] [Related]
15. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase. Preusch PC, Suttie JW. Arch Biochem Biophys; 1984 Nov 01; 234(2):405-12. PubMed ID: 6497379 [Abstract] [Full Text] [Related]
16. A comparison of warfarin resistance and liver microsomal vitamin K epoxide reductase activity in rats. MacNicoll AD. Biochim Biophys Acta; 1985 May 29; 840(1):13-20. PubMed ID: 3995080 [Abstract] [Full Text] [Related]
17. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes. Hildebrandt EF, Preusch PC, Patterson JL, Suttie JW. Arch Biochem Biophys; 1984 Feb 01; 228(2):480-92. PubMed ID: 6696443 [Abstract] [Full Text] [Related]
18. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat. Fasco MJ, Principe LM. J Biol Chem; 1982 May 10; 257(9):4894-901. PubMed ID: 7068669 [Abstract] [Full Text] [Related]
19. 2-(Fluoromethyl)-3-phytyl-1,4-naphthoquinone and its 2,3-epoxide. Inhibition of vitamin K epoxide reductase. Silverman RB, Oliver JS. J Med Chem; 1989 Sep 10; 32(9):2138-41. PubMed ID: 2769684 [Abstract] [Full Text] [Related]